![Navid Ashrafi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 366 141 $ as of 30/06/2026
Navid Ashrafi is currently the Director-Medical & Regulatory Affairs at BioSyent, Inc. He previously worked as the Head-Business Unit at Bayer Parsian AG.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOSYENT INC. 0.31% | 30/06/2026 | 35,861 ( 0.31% ) | 366 141 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOSYENT INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
| Companies | Position | End |
|---|---|---|
Bayer Parsian AG
 Bayer Parsian AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
BioSyent, Inc.
 BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Bayer Parsian AG
Bayer Parsian AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
